Literature DB >> 20586143

Effect of ankaferd blood stopper on hemostasis and histopathological score in experimental liver injury.

Mustafa Uygar Kalayci1, Aliye Soylu, Hasan Erol Eroglu, Dilek Kubilay, Banu Sancak, Ceyhan Ugurluoglu, Ugur Ercin, Yavuz Koca, Oguzhan Karatepe.   

Abstract

AIM: To investigate intra-abdominal, local histopathological and hemostatic effects of Ankaferd (ABS) in an experimental liver injury.
METHODS: Forty rats were randomly assigned to the primary suture group (PS) (n = 15), ABS group (n = 15) and control group (n = 10). A wedge resection was performed on the left lobe of the liver. In the primary suture group, the liver was sutured with polypropylene material, while in ABS group the liver surface was covered with ABS. Adhesion, histo-pathological scores and hydroxyproline levels were measured postoperatively on day 3 and day 15.
RESULTS: The mean bleeding time was 7.5 sec shorter in the ABS group (6.5 sec-13.5 sec) and 107 sec shorter in PS group. AST, ALT, total bilirubin and ALP values complete blood count (CBC) did not change. Intra-abdominal adhesions were the same in PS and ABS groups on 3rd (2.20 +/- 1.30 vs 2.0 +/- 1.11) and 15th (1.60 +/- 0.54 vs 1.25 +/- 0.7) days postoperatively. Histopathological scores were better in the ABS group than in the primary suture group on 3rd (2.5 +/- 0.5 vs 5.25 +/- 0.2, p = 0.006) and 15th (1.65 +/- 1.7 vs 3.15 +/- 1.0, p = 0.025) days postoperatively. Hydroxyproline levels were higher in ABS group on postoperative 15th day (17.12 microg/tissue vs 13.69 microg/tissue; p = 0.005).
CONCLUSION: These data suggest that ABS in experimental liver trauma causes favorable histopathological scores and shorter hemostasis time and higher hydroxyproline levels (Tab. 2, Fig. 2, Ref. 35).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586143

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  4 in total

1.  Unpredicted effects of Ankaferd® on cartilage tissue.

Authors:  Cenk Evren; Mehmet Birol Uğur; Burhan Yıldırım; Sibel Bektaş; Volkan Bilge Yiğit; Fikret Çınar
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Local use of ankaferd blood clotter in emergent beating heart coronary artery bypass grafting.

Authors:  Hakan Atalay; Atakan Atalay; Omer F Dogan
Journal:  Open Cardiovasc Med J       Date:  2015-02-27

3.  Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model.

Authors:  Erdem Koçak; Erdem Akbal; Adnan Taş; Seyfettin Köklü; Gökhan Karaca; Murat Can; Bahadir Kösem; Hüseyin Üstün
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

4.  Effect of ankaferd blood stopper in experimental peritoneal adhesion model.

Authors:  Gokhan Karaca; Oktay Aydin; Faruk Pehlivanli; Ahmet Kocael; Recep Pekcici; Esat Duymus; Sukran Akgedik; Osman Guler
Journal:  Ann Surg Treat Res       Date:  2016-03-30       Impact factor: 1.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.